These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10183009)

  • 1. The demographic impact on ambulatory pharmaceutical expenditure in Belgium.
    Van Tielen R; Peys F; Genaert J
    Health Policy; 1998 Jul; 45(1):1-14. PubMed ID: 10183009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
    Tin KY; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK
    Hong Kong Med J; 2015 Jun; 21(3 Suppl 3):1-24. PubMed ID: 26045183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Booming prescription drug expenditure: a population-based analysis of age dynamics.
    Morgan SG
    Med Care; 2005 Oct; 43(10):996-1008. PubMed ID: 16166869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Real per capita health spending by age and sex in Spain (1998-2008): changes and effects on public healthcare expenditure projections].
    Blanco Moreno Á; Urbanos Garrido R; Thuissard Vasallo IJ
    Gac Sanit; 2013; 27(3):220-5. PubMed ID: 23140979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in drug utilization in Israel.
    Sax P
    Isr J Med Sci; 1992 Oct; 28(10):718-25. PubMed ID: 1399502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The drug budget silo mentality: the French case.
    Le Pen C
    Value Health; 2003; 6 Suppl 1():S10-9. PubMed ID: 12846922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond survey data: a claims-based analysis of drug use and spending by the elderly.
    Steinberg EP; Gutierrez B; Momani A; Boscarino JA; Neuman P; Deverka P
    Health Aff (Millwood); 2000; 19(2):198-211. PubMed ID: 10718034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2013 Apr; 19(2 Suppl 3):1-24. PubMed ID: 23589588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drugs and the changing concentration of health care expenditures.
    Zuvekas SH; Cohen JW
    Health Aff (Millwood); 2007; 26(1):249-57. PubMed ID: 17211035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pharmaceutical cost of elderly people in private health insurance].
    Wild F
    Versicherungsmedizin; 2009 Dec; 61(4):159-62. PubMed ID: 20052826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical cost-containment policy: experiences in Shanghai, China.
    Hu S; Chen W; Cheng X; Chen K; Zhou H; Wang L
    Health Policy Plan; 2001 Dec; 16 Suppl 2():4-9. PubMed ID: 11772985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Australian government health expenditure by age: a fiscal incidence analysis.
    Tapper A; Phillimore J
    Aust Health Rev; 2014 Nov; 38(5):523-7. PubMed ID: 25164547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domestic health expenditure in Hong Kong: 1989/90 to 2001/02.
    Leung GM; Tin KY; Yeung RY; Rannan-Eliya R; Leung ES; Lam DW; Lo SV
    Hong Kong Med J; 2006 Feb; 12(1):47-55. PubMed ID: 16495589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hong Kong domestic health spending: financial years 1989/90 to 2005/06.
    Tin KY; Tsoi PK; Leung ES; Tsui EL; Lam DW; Tsang CS; Lo SV
    Hong Kong Med J; 2010 Feb; 16 Suppl 2():1-23. PubMed ID: 20393228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.